心律管理设备市场规模、份额、成长分析、按产品、按最终用户、按地区 - 行业预测，2024-2031 年

Cardiac Rhythm Management Devices Market Size, Share, Growth Analysis, By Product (Pacemakers, Defibrillators), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年心律管理设备的市场规模为188亿美元，从2023年的198.3亿美元增长到2031年的304.4亿美元，预计在预测期内（2024-2031年）复合年增长率为5.5%。

由于心房颤动、心律不整和心臟衰竭等心血管疾病盛行率不断上升，以及对有效治疗解决方案的需求不断增加，心律管理设备市场正在经历强劲增长。人口老化进一步加剧了这一趋势，而人口老化本来就更容易罹患心臟相关疾病。技术进步，特别是在设备小型化、无线连接和先进演算法方面的进步，大大提高了这些设备的性能和准确性。植入式心臟整流去颤器(ICD)、心律调节器和心臟再同步治疗 (CRT) 等创新治疗方法的出现彻底改变了心律不整的治疗。竞争格局正在发生变化，Medtronic plc、Abbott Laboratories、Boston Scientific Corporation、Biotronik SE &Co.KG 和 St. Jude Medical, Inc. 等主要企业专注于研发以推动创新并确保其市场地位。因此，由于心血管疾病盛行率不断上升、技术不断进步以及老年人口不断增长，全球心律管理设备市场预计将保持其成长轨迹。随着诊断和治疗能力的不断进步，改善患者的治疗效果和生活质量，预计美国市场在未来几年将出现持续的复合年增长率。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Physio-Control, Inc.（Stryker）（US）
BIOTRONIK（Germany）
Schiller（Switzerland）
Medtronic（US）
Abbott（US）
Koninklijke Philips NV（Netherlands）
Zoll Medical Corporation（US）
Boston Scientific Corporation（US）
Progetti Srl（Italy）
LivaNova Plc（UK）
Impella（ABIOMED, US）
AngioDynamics, Inc.（US）
MicroPort Scientific Corporation（China）
Edwards Lifesciences Corporation（US）
Getinge AB（Sweden）
Synchrony Medical（US）
Osypka AG（Germany）
Inspire Medical Systems, Inc.（US）
AtriCure, Inc.（US）
Apex Medical（Taiwan）
Biotronik SE & Co. KG（Germany）
VivaSonic Inc.（US）

简介目录

Product Code: SQMIG35A2577

Cardiac Rhythm Management Devices Market size was valued at USD 18.80 billion in 2022 and is poised to grow from USD 19.83 billion in 2023 to USD 30.44 billion by 2031, at a CAGR of 5.5% during the forecast period (2024-2031)

The cardiac rhythm management devices market is experiencing robust growth, propelled by the rising incidence of cardiovascular conditions such as atrial fibrillation, arrhythmias, and heart failure, leading to an increased demand for effective treatment solutions. This trend is further amplified by the expanding geriatric population, which is inherently more vulnerable to heart-related ailments. Technological advancements, particularly in device miniaturization, wireless connectivity, and sophisticated algorithms, have significantly enhanced the performance and accuracy of these devices. The emergence of innovative treatments, such as implantable cardioverter-defibrillators (ICDs), pacemakers, and cardiac resynchronization therapy (CRT), has transformed the management of cardiac rhythm disorders. The competitive landscape is marked by key players such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, and St. Jude Medical, Inc., who are heavily investing in research and development to drive innovation and secure their market positions. As a result, the global cardiac rhythm management devices market is projected to sustain its growth trajectory, driven by a confluence of increasing cardiovascular disease prevalence, ongoing technological enhancement, and a growing older population. In particular, the U.S. market is anticipated to experience sustainable compound annual growth rate (CAGR) in the forthcoming years, with continual advancements set to bolster diagnosis and treatment capabilities, thereby enhancing overall patient outcomes and quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Rhythm Management Devices Market Segmental Analysis

Global Cardiac Rhythm Management Devices Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Pacemakers, and Defibrillators. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgery Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiac Rhythm Management Devices Market

The alarming rise in physical inactivity, identified as the second leading cause of death in the US, is a significant market driver for the Cardiac Rhythm Management Devices market. With sedentary lifestyles contributing to a heightened prevalence of chronic diseases such as diabetes and cardiovascular disorders, there is an increasing need for effective monitoring and management solutions. The World Health Organization's estimate of approximately 2 million deaths annually due to inactivity underscores the urgency for advanced cardiac devices. As more individuals become affected by heart conditions linked to a lack of exercise, demand for innovative cardiac rhythm management technologies is projected to surge in both developed and developing nations.

Restraints in the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market faces significant restraints primarily due to the high costs associated with these advanced technologies, which can limit accessibility for both patients and healthcare providers, particularly in developing regions. Furthermore, the shortage of qualified healthcare professionals trained in the usage and maintenance of these devices exacerbates the issue, hindering optimal patient care and device efficacy. Additionally, the limited number of healthcare facilities capable of providing such specialized treatments further dampens market growth. Collectively, these factors contribute to a restrictive environment for market expansion in regions that critically need improved cardiac care solutions.

Market Trends of the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market is witnessing a significant trend towards personalized medicine, emphasizing the customization of treatment strategies to align with individual patient profiles. This shift is fueled by the development of advanced devices equipped with adaptive algorithms and machine learning capabilities, which enable healthcare providers to deliver tailored therapies that enhance patient outcomes. As a result, there is growing investment in innovative technologies that can analyze real-time data and adjust treatment protocols, fostering a more precise approach to managing cardiac conditions. This trend not only improves patient engagement but also drives market growth and competitiveness within the sector.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Cardiac Rhythm Management Devices Market by Product

Market Overview
Pacemakers
- Implantable
- External
Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- S-ICD
- T-ICD
- External Defibrillator
- Manual External Defibrillator
- Automatic External Defibrillator
- Wearable Cardioverter Defibrillator
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillator
- CRT-Pacemakers

Cardiac Rhythm Management Devices Market by End User

Market Overview
Hospitals & Clinics
Ambulatory Surgery Centers
Others

Cardiac Rhythm Management Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Physio-Control, Inc. (Stryker) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoll Medical Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti Srl (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Impella (ABIOMED, US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synchrony Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspire Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apex Medical (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VivaSonic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments